FILTER

FILTERED INTERVIEW RESULTS

Mining
Chile

Andrés Costa

MANAGING DIRECTOR, SGS CHILE
Chile Mining 2021
SGS Chile explains why it is upbeat for growth in Chile.
Mining
Chile

Simao Antunes

GENERAL MANAGER SOUTH AMERICA, HOFMANN ENGINEERING
Chile Mining 2021
Hofmann Engineering explains how it is expanding into South America.
Mining
Peru

Javier Schmal

VICE PRESIDENT – LATIN AMERICA, MARTIN ENGINEERING
Martin Engineering explains how it is applying technology to improve its product line.
Mining
Peru

Dustin Angelo

PRESIDENT, CEO AND CO-FOUNDER, NOVAMERA INC.
Novamera explains how its drilling technology provides a pathway for companies to start projects that were previously was not economically feasible, or to add existing mineral resources outside of their mine plan to their operations.
Mining
South Africa
MACIG

Errol Smart

MANAGING DIRECTOR & CEO, ORION MINERALS
Orion Minerals explains its vision to grow into a sustainable mid-tier, green metal producer in the near future.
Mining
Namibia
MACIG

André Snyman

MANAGING DIRECTOR, WALVIS BAY SALT HOLDINGS
Walvis Bay Salt Holdings explains what is needed to successfully grow industry in Namibia.
Mining
Canada

Cesar Inostroza

SENIOR VICE-PRESIDENT-MINING AND METALLURGY, SNC-LAVALIN
SNC-Lavalin explains why Québec is well placed to feed the battery metal supply chain.
Mining
Canada

David Cataford

CEO, CHAMPION IRON LIMITED
Champion Iron explains progress at its Bloom Lake iron project in northern Québec.
Mining
Canada

Sandeep Singh

PRESIDENT & CEO, OSISKO GOLD ROYALTIES
Osisko Gold Royalties speaks to GBR of its portfolio of assets in Québec and beyond.
Mining
Chile

Francisco Casas

GENERAL MANAGER, NEXXO
Chile Mining 2021
Nexxo explains how its experience in mechanical maintenance for the petroleum industry is being put to use by Chile’s miners.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL